Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: A prospective randomized controlled trial

Knee Surgery, Sports Traumatology, Arthroscopy

Volumn 21, Issue 11, 2013, Pages 2611-2617

  Lee, Sang Hak ^a   Cho, Kye Youl ^a   Khurana, Sumit ^a   Kim, Kang Il ^a  

^a Kyung Hee University College of Medicine   (South Korea)

Author keywords

Deep vein thrombosis; Fondaparinux; Total knee arthroplasty; Tranexamic acid

Indexed keywords

ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 10A; FONDAPARINUX; POLYSACCHARIDE; TRANEXAMIC ACID;

AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; FEMALE; HUMAN; KNEE ARTHROPLASTY; KNEE OSTEOARTHRITIS; MALE; MIDDLE AGED; OPERATIVE BLOOD LOSS; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VENOUS THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; FACTOR XA; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; POLYSACCHARIDES; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; TRANEXAMIC ACID; VENOUS THROMBOEMBOLISM;

EID: 84885953472     PISSN: 09422056     EISSN: 14337347     Source Type: Journal    
DOI: 10.1007/s00167-012-2213-1     Document Type: Article

References (42)

1. Benoni G, Fredin H (1996) Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 78: 434-440.
2. Eikelboom JW, Quinlan DJ, Douketis JD (2001) Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 358: 9-15.
3. Ekback G, Axelsson K, Ryttberg L, Edlund B, Kjellberg J, Weckstrom J, Carlsson O, Schott U (2000) Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg 91: 1124-1130.
4. Engel JM, Hohaus T, Ruwoldt R, Menges T, Jurgensen I, Hempelmann G (2001) Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg 92: 775-780.
5. Eriksson O, Kjellman H, Pilbrant A, Schannong M (1974) Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers. Eur J Clin Pharmacol 7: 375-380.
6. Guijarro R, Montes J, San Roman C, Arcelus JI, Barillari G, Granero X, Monreal M (2011) Venous thromboembolism and bleeding after total knee and hip arthroplasty. Findings from the Spanish National Discharge Database. Thromb Haemost 105: 610-615.
7. Hiippala ST, Strid LJ, Wennerstrand MI, Arvela JV, Niemela HM, Mantyla SK, Kuisma RP, Ylinen JE (1997) Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 84: 839-844.
8. Howes JP, Sharma V, Cohen AT (1996) Tranexamic acid reduces blood loss after knee arthroplasty. J Bone Joint Surg Br 78: 995-996.
9. Hynes M, Calder P, Scott G (2003) The use of tranexamic acid to reduce blood loss during total knee arthroplasty. Knee 10: 375-377.
10. Hynes MC, Calder P, Rosenfeld P, Scott G (2005) The use of tranexamic acid to reduce blood loss during total hip arthroplasty: an observational study. Ann R Coll Surg Engl 87: 99-101.
11. Jansen AJ, Andreica S, Claeys M, D'Haese J, Camu F, Jochmans K (1999) Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 83: 596-601.
12. Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W (2009) Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 123: 687-696.
13. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ (2008) Antithrombotic therapy for venous thromboembolic disease: American college of chest physicians evidence-based clinical practice guidelines (8th Edition). Chest 133: 454S-545S.
14. Kim KI, Cho KY, Jin W, Khurana SS, Bae DK (2011) Recent Korean perspective of deep vein thrombosis after total knee arthroplasty. J Arthroplast 26: 1112-1116.
15. Kim YH, Kim JS (2002) Incidence and natural history of deep-vein thrombosis after total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg Br 84: 566-570.
16. Lachiewicz PF (2011) Comparing and contrasting current guidelines for venous thromboembolism prophylaxis after total hip and total knee arthroplasty. Instr Course Lect 60: 301-307.
17. Lemaire R (2008) Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg Br 90: 1128-1136.
18. Lieberman JR, Hsu WK (2005) Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am 87: 2097-2112.
19. Lin PC, Hsu CH, Chen WS, Wang JW (2011) Does tranexamic acid save blood in minimally invasive total knee arthroplasty? Clin Orthop Relat Res 469: 1995-2002.
20. Lozano M, Basora M, Peidro L, Merino I, Segur JM, Pereira A, Salazar F, Cid J, Lozano L, Mazzara R, Macule F (2008) Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sang 95: 39-44.
21. MacGillivray RG, Tarabichi SB, Hawari MF, Raoof NT (2011) Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. J Arthroplast 26: 24-28.
22. Oishi CS, Grady-Benson JC, Otis SM, Colwell CW Jr, Walker RH (1994) The clinical course of distal deep venous thrombosis after total hip and total knee arthroplasty, as determined with duplex ultrasonography. J Bone Joint Surg Am 76: 1658-1663.
23. Onodera T, Majima T, Sawaguchi N, Kasahara Y, Ishigaki T, Minami A (2012) Risk of deep venous thrombosis in drain clamping with tranexamic acid and carbazochrome sodium sulfonate hydrate in total knee arthroplasty. J Arthroplast 27: 105-108.
24. Orpen NM, Little C, Walker G, Crawfurd EJ (2006) Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee 13: 106-110.
25. Rajesparan K, Biant LC, Ahmad M, Field RE (2009) The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br 91: 776-783.
26. Salido JA, Marin LA, Gomez LA, Zorrilla P, Martinez C (2002) Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 84-A: 216-220.
27. Seo JG, Moon YW, Park SH, Kim SM, Ko KR (2012) The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc doi: 10. 1007/s00167-012-2079-2.
28. Stulberg BN, Insall JN, Williams GW, Ghelman B (1984) Deep-vein thrombosis following total knee replacement. An analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg Am 66: 194-201.
29. Sukeik M, Alshryda S, Haddad FS, Mason JM (2011) Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 93: 39-46.
30. Sundstrom A, Seaman H, Kieler H, Alfredsson L (2009) The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the general practice research database. BJOG 116: 91-97.
31. Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S (2001) Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br 83: 702-705.
32. Toftdahl K, Nikolajsen L, Haraldsted V, Madsen F, Tonnesen EK, Soballe K (2007) Comparison of peri- and intraarticular analgesia with femoral nerve block after total knee arthroplasty: a randomized clinical trial. Acta Orthop 78: 172-179.
33. Trca S, Krska Z, Sedlar M, Kudrnova Z, Dohnalova A (2007) Comparison of various types of pharmacological prevention of lower extremities deep vein thrombosis in patients with proximal femoral fractures. Rozhl Chir 86: 241-248.
34. Walzman M, Bonnar J (1982) Effects of tranexamic acid on the coagulation and fibrinolytic systems in pregnancy complicated by placental bleeding. Arch Toxicol Suppl 5: 214-220.
35. Wang CJ, Wang JW, Chen LM, Chen HS, Yang BY, Cheng SM (2000) Deep vein thrombosis after total knee arthroplasty. J Formos Med Assoc 99: 848-853.
36. Wang CJ, Wang JW, Weng LH, Hsu CC, Huang CC, Yu PC (2004) Prevention of deep-vein thrombosis after total knee arthroplasty in Asian patients. Comparison of low-molecular-weight heparin and indomethacin. J Bone Joint Surg Am 86-A: 136-140.
37. Watanabe H, Sekiya H, Kariya Y, Hoshino Y, Sugimoto H, Hayasaka S (2011) The incidence of venous thromboembolism before and after total knee arthroplasty using 16-row multidetector computed tomography. J Arthroplast 26: 1488-1493.
38. White RH, Goulet JA, Bray TJ, Daschbach MM, McGahan JP, Hartling RP (1990) Deep-vein thrombosis after fracture of the pelvis: assessment with serial duplex-ultrasound screening. J Bone Joint Surg Am 72: 495-500.
39. Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, Syed KA, Muhammad Ovais Hasan S, De Silva Y, Chung F (2010) Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 92: 2503-2513.
40. Xu ZQ, Li Y, Liao RZ, Fang YZ, Liu ZH (2010) Clinical analysis of preoperative deep venous thrombosis (DVT) complicated lower extremity close fractures. Zhongguo Gu Shang 23: 52-54.
41. Zhang H, Chen J, Chen F, Que W (2012) The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 20: 1742-1752.
42. Zohar E, Ellis M, Ifrach N, Stern A, Sapir O, Fredman B (2004) The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg 99: 1679-1683.